LNAI
Lunai Bioworks Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.39
+1.70%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$10.84M
MomentumView details →
1D Return
+1.70%
YTD Return
−67.38%
RSI (14)
48.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$10.84M
RSI (14)
48.2
MomentumView details →
1D Return
+1.70%
YTD Return
−67.38%
Similar companies
Latest newsMore news →
Lunai Bioworks filed a second amended complaint in its naked short selling lawsuit, adding six broker-dealers as defendants and alleging securities fraud and market manipulation under Rule 10b-5.8d agoLunai Bioworks signed a definitive collaboration agreement with BrainStorm Therapeutics, with initial Parkinson's disease data readout targeted for the first half of 2027.31d agoLunai Bioworks filed an amended complaint in a lawsuit naming 10 defendants for naked short selling fraud, alleging 29.6 million failed-to-deliver shares and seeking treble damages under federal RICO statute.31d ago